Despite the consensus-beating Q1 profitability, the management was not overly enthusiastic. Interestingly, the Specialty margin fell by less than that of Intermediates, but both parts of the company faced the same triggers for this development. Sales were missed by -1.2% and consensus on the the adjusted EBITDA was beaten by +12.2%.